Caisse de Depot et Placement du Quebec (CDPQ)’s Charles River Laboratories CRL Stock Holding History

Caisse de Depot et Placement du Quebec (CDPQ)’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$6.97M	Buy	+40,377	New	+$7.49M	0.01%	471
2025 Q4	–	Sell	-14,000	Closed	-$2.19M	–	557
2025 Q3	$2.19M	Buy	+14,000	New	+$2.22M	﹤0.01%	500
2025 Q2	–	Sell	-85,000	Closed	-$12.8M	–	515
2025 Q1	$12.8M	Buy	+85,000	New	+$14.3M	0.03%	357
2023 Q4	–	Sell	-14,500	Closed	-$2.84M	–	492
2023 Q3	$2.84M	Buy	+14,500	New	+$2.98M	0.01%	372
2022 Q2	–	Sell	-7,800	Closed	-$2.21M	–	602
2022 Q1	$2.21M	Buy	7,800 +100	+1%	+$30.8K	0.01%	498
2021 Q4	$2.9M	Buy	7,700 +6,200	+413%	+$2.41M	0.01%	433
2021 Q3	$619K	Buy	1,500 +100	+7%	+$41.5K	﹤0.01%	489
2021 Q2	$518K	Buy	+1,400	New	+$467K	﹤0.01%	469
2018 Q1	–	Sell	-40,000	Closed	-$4.38M	–	736
2017 Q4	$4.38M	Buy	+40,000	New	+$4.35M	0.01%	379

Other funds holding CRL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Caisse de Depot et Placement du Quebec (CDPQ)'s CRL Position: Q1 2026 in Review

Caisse de Depot et Placement du Quebec (CDPQ) opened a new position in Charles River Laboratories (CRL) in Q1 2026: 40,377 shares worth $6.97M. The stake represents 0.01% of the portfolio and ranks #471 among its holdings. This is a return to the name: Caisse de Depot et Placement du Quebec (CDPQ) previously reported a position in CRL as recently as Q3 2025.

Caisse de Depot et Placement du Quebec (CDPQ) first reported a position in CRL in Q4 2017 and has held it in 9 quarters since. The position peaked at $12.8M in Q1 2025. 558 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

Caisse de Depot et Placement du Quebec (CDPQ) held 40,377 shares of Charles River Laboratories worth $6.97M as of Q1 2026.
Charles River Laboratories was a new Caisse de Depot et Placement du Quebec (CDPQ) position in Q1 2026.
Charles River Laboratories made up 0.01% of Caisse de Depot et Placement du Quebec (CDPQ)'s portfolio in Q1 2026, its #471 holding.
Caisse de Depot et Placement du Quebec (CDPQ) first reported a position in Charles River Laboratories in Q4 2017 and has held it in 9 quarters since.
Caisse de Depot et Placement du Quebec (CDPQ)'s Charles River Laboratories position peaked at $12.8M in Q1 2025.
558 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Caisse de Depot et Placement du Quebec (CDPQ)'s 13F filing for Q1 2026, filed 14 May 2026.